Diabetes decisions — 2026

The Board has remanded the claims for service connection for diabetes mellitus, type II; prostate cancer; cardiovascular disorder; SMC based upon loss of use of a creative organ; and erectile dysfunction due to potential direct links between these conditions and in-service events. The VA is required to obtain new opinions regarding the etiology of the Veteran's diagnosed disabilities.

The Veteran's service-connected coronary artery disease, along with other disabilities, rendered him unable to secure and follow substantially gainful employment prior to June 10, 2024. The appeal for a higher rating for coronary artery disease was denied.

The Veteran's claims for service connection for depression and obstructive sleep apnea have been remanded due to the need for a VA examination.,The Veteran's claims for service connection for type II diabetes mellitus, migraines, and vertigo remain denied as there is no new and relevant evidence received since the August 2018 rating decision.

The Veteran's claim for an earlier effective date for the 30 percent evaluation assigned for right upper extremity diabetic neuropathy prior to March 28, 2024 is being remanded due to a pre-decisional error in the August 2024 rating decision.

The Veteran's PTSD, diabetes mellitus, and related neuropathies have rendered him unable to secure or follow substantially gainful employment since June 21, 2018. The effective date for the TDIU is set as of that date.

The Veteran's PTSD is rated at 70 percent from October 4, 2021. The rating for his diabetes mellitus remains at 20 percent.

The Veteran's tinnitus is granted as service connection due to credible reports of ongoing symptoms since service.,Service connection for allergic rhinitis, colonic bleeds, CAD, hypothyroidism, diabetes mellitus type II, left carotid stenosis, and sleep apnea are remanded due to inadequate VA medical opinions.

The Board dismissed the Veteran's appeal for an earlier effective date of December 24, 2021, for his service-connected diabetes. The Veteran submitted a supplemental claim in July 2023 and identified the benefit sought as 'diabetes mellitus, type II - 10% - service connection for diabetes mellitus, type II associated with herbicide exposure is granted with a 10.' However, the Board found that the submission was untimely and did not demonstrate an intent to seek an earlier effective date.

The Board has remanded the claims for diabetes mellitus type II, neck disability, back disability, left hip disability, and right hip disability due to duty-to-assist errors identified during a Higher-Level Review (HLR). The Veteran is seeking service connection under the PACT Act for toxic exposures in service.

The Board has granted service connection for diabetes mellitus, stroke residuals as secondary to service-connected diabetes mellitus, and right leg amputation as secondary to service-connected diabetes mellitus. The decision is based on the Veteran's in-service exposure to toxic fumes, chemicals, and AFFF which are believed to have caused his current disabilities.

The Veteran's bilateral senile cataracts were rated as noncompensable prior to March 30, 2021, and a 10 percent rating thereafter. The Veteran was granted TDIU from October 2, 2013, to March 27, 2019.

The Board has determined that the Veteran's service connection claims for CAD with coronary bypass graft, voiding dysfunction status post prostate cancer, DM type II with ED, and hypertension are denied as there is no evidence of herbicide exposure during service or a link to service.

The Veteran's chest pain, diabetes mellitus type II, GERD, and pes planus have not been found to be related to service.,There is no evidence of a current disability for any of the claimed conditions.

The Veteran's service-connected disabilities, particularly his back disability and PTSD, have rendered him unable to secure and maintain substantially gainful employment.

The Board has decided to remand the case due to a pre-decisional duty to assist error and will consider any evidence submitted after the AOJ decision on appeal. The Veteran's claim for service connection for sleep apnea was previously denied, but there is new evidence received by the RO that supports this finding.

The Board has granted effective dates of August 28, 2006 for the award of service connection for diabetic peripheral neuropathy of both lower extremities. The decision is based on evidence that was not previously considered due to misfiled documents and lay statements.

The Veteran's diabetes, which is rated at a 20 percent rating since September 27, 2021, has been granted. The Veteran's service-connected coronary artery disease (CAD) was previously rated at 100 percent and remains so.

The Veteran's endometrial carcinoma is granted service connection on a direct basis due to exposure at Camp Lejeune. Service connection for diabetes is dismissed.

The Board has remanded the claims for service connection due to a failure to prepare a TERA memorandum considering the Veteran's exposure to burn pits in Iraq and Molotov cocktails in the Philippines.

The Veteran's service-connected disabilities rendered him unable to secure or follow substantially gainful employment prior to June 19, 2012.